CLOV vs DAWN
Clover Health Investments Corp (CLOV) versus Day One Biopharmaceuticals Inc (DAWN) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Day One Biopharmaceuticals Inc (DAWN) is a biotechnology company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported DAWN revenue for 2024-12-31 was $131.2M. Net income was -$95.5M. DAWN currently screens at market cap $656.8M.
CLOV currently screens at market cap $1.55B. DAWN currently screens at market cap $656.8M.
Not investment advice. Open the CLOV and DAWN stock pages for the full models.
Not investment advice.